INVIVO Co. Ltd., 121, Nonsan 32992, Republic of Korea; Department of Pathology, College of Korean Medicine, Wonkwang University, Iksan 54651, Republic of Korea.
INVIVO Co. Ltd., 121, Nonsan 32992, Republic of Korea.
Int J Biol Macromol. 2024 May;268(Pt 2):131908. doi: 10.1016/j.ijbiomac.2024.131908. Epub 2024 Apr 26.
Curcuma longa and Sargassum coreanum are commonly used in traditional pharmaceutical medicine to improve immune function in chronic diseases. The present study was designed to systematically elucidate the in vitro and in vivo immuno-enhancing effects of a combination of C. longa and S. coreanum extracts (CS) that contain polyphenols and saccharides as functional molecules in a cyclophosphamide (Cy)-induced model of immunosuppression. In primary splenocytes, we observed the ameliorative effects of CS on a Cy-induced immunosuppression model with low cytotoxicity and an optimal mixture procedure. CS treatment enhanced T- and B-cell proliferation, increased splenic natural killer-cell activity, and restored cytokine release. Wistar rats were orally administered low (30 mg/kg), intermediate (100 mg/kg), or high (300 mg/kg) doses of CS for four weeks, followed by oral administration of Cy (5 mg/kg) for four weeks. Compared with the vehicle group, low-, intermediate-, and high-dose CS treatment accelerated dose-dependent recovery of the serum level of tumor necrosis factor-α, interferon-γ, interleukin-2, and interleukin-12. These results suggest that CS treatment accelerates the amelioration of immune deficiency in Cy-treated primary splenocytes and rats, which supports considering it for immunity maintenance. Our findings provide experimental evidence for further research and clinical application in immunosuppressed patients.
姜黄和昆布是传统医药中常用的草药,用于改善慢性病患者的免疫功能。本研究旨在系统阐明姜黄和昆布提取物(CS)的体外和体内免疫增强作用,CS 含有多酚和作为功能分子的多糖,用于环磷酰胺(Cy)诱导的免疫抑制模型。在原代脾细胞中,我们观察到 CS 在低细胞毒性和最佳混合程序下对 Cy 诱导的免疫抑制模型的改善作用。CS 处理增强了 T 和 B 细胞的增殖,增加了脾自然杀伤细胞的活性,并恢复了细胞因子的释放。Wistar 大鼠连续四周口服低(30mg/kg)、中(100mg/kg)和高(300mg/kg)剂量的 CS,然后再连续四周口服 Cy(5mg/kg)。与对照组相比,低、中、高剂量 CS 治疗加速了 TNF-α、IFN-γ、IL-2 和 IL-12 血清水平的剂量依赖性恢复。这些结果表明 CS 治疗可加速改善 Cy 处理的原代脾细胞和大鼠的免疫缺陷,支持将其用于免疫维持。我们的研究结果为进一步研究和临床应用于免疫抑制患者提供了实验依据。